Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
26/09/202214h00Business WireTeva Launches Honestly HD Website to Provide People Living With Huntington’s Disease (HD) Information, Inspiration and Resources on HD ChoreaNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/202221h58Business WireDes études démontrent l'efficacité d'AJOVY®▼ (frémanézumab) dans le traitement de la migraine chez des patients présentant une dépression comorbideNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/202220h29Business WireStudien zeigen Wirksamkeit von AJOVY®▼ (Fremanezumab) bei der Behandlung von Migräne bei Patientinnen und Patienten mit komorbider DepressionNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/202207h45Business WireStudies Show Effectiveness of AJOVY®▼ (fremanezumab) for Treatment of Migraine in Patients With Co-morbid DepressionNYSE:TEVATeva Pharmaceutical Industries Ltd
07/09/202214h00Business WireCONNECT1 Study Published in Journal of Allergy and Clinical Immunology: In Practice Evaluates the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder and Digihaler System to Help Improve Asthma ManagementNYSE:TEVATeva Pharmaceutical Industries Ltd
29/08/202218h26Business WireLa Commission européenne accorde une autorisation de mise sur le marché à Ranivisio▼®* (ranibizumab), un biosimilaire du Lucentis®**, pour le traitement de la dégénérescence maculaire liée à l'âge (DMLA), cause la plus fréquente de cécité dNYSE:TEVATeva Pharmaceutical Industries Ltd
29/08/202217h56Business WireEuropäische Kommission erteilt Marktzulassung für Ranivisio▼®* (Ranibizumab), ein Biosimilar von Lucentis®** zur Behandlung von altersbedingter Makuladegeneration (AMD), der häufigsten Ursache für Erblindung in IndustrieländernNYSE:TEVATeva Pharmaceutical Industries Ltd
29/08/202214h00Business WireTeva to Present First Data Set from the CONNECT1 Clinical Trial on ProAir® Digihaler® (albuterol sulfate) Inhalation Powder at the European Respiratory Society (ERS) International Congress 2022NYSE:TEVATeva Pharmaceutical Industries Ltd
29/08/202208h00Business WireEuropean Commission grants marketing authorization for Ranivisio▼®* (ranibizumab), a biosimilar to Lucentis®**, for age-related macular degeneration (AMD) the most common cause of blindness in developed countriesNYSE:TEVATeva Pharmaceutical Industries Ltd
24/08/202213h51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/202213h11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/202214h36TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Teva Pharmaceutical (TEVA), HUTCHMED (HCM) and Arcutis Biotherapeutics (ARQT)NYSE:TEVATeva Pharmaceutical Industries Ltd
29/07/202214h21TipRanksJ.P. Morgan Maintains Their Hold Rating on Teva Pharmaceutical (TEVA)NYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/202222h07Edgar (US Regulatory)Quarterly Report (10-q)NYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/202216h21TipRanksHere’s Why Teva Shares are Trending Higher TodayNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/202213h31TipRanksThese Stocks Are the Biggest Pre-Market Movers on WednesdayNYSE:TEVATeva Pharmaceutical Industries Ltd
26/07/202223h53Dow Jones NewsTeva Pharma ADRs Jump 17% On Pending Nationwide Agreement Over Opioid LitigationNYSE:TEVATeva Pharmaceutical Industries Ltd
26/07/202222h55Business WireTeva Reports Second Quarter 2022 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
25/07/202214h00GlobeNewswire Inc.Certara Appoints Rosemary Crane as New Independent Board MemberNYSE:TEVATeva Pharmaceutical Industries Ltd
13/07/202215h53PR Newswire (US)Teva Pharmaceuticals accredited Migraine Friendly Workplace StampNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202223h05Dow Jones NewsADRs End Lower; Teva Pharmaceutical, Banco Santander Trade ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202218h39Dow Jones NewsTeva Pharmaceutical, Abbvie's Allergan Settle Opioid Suit With San Francisco -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202217h38Dow Jones NewsTeva Pharmaceutical, Abbvie's Allergan Settle Opioid Suit With San FranciscoNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202216h30Business WireTeva Reaches Agreement With San Francisco to Settle Opioid-Related ClaimsNYSE:TEVATeva Pharmaceutical Industries Ltd
11/07/202217h11Dow Jones NewsNew York Attorney General Seeks to Bring Teva Back Into Opioid Case -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
11/07/202216h31Dow Jones NewsNew York Attorney General Seeks to Bring Teva Back Into Opioid CaseNYSE:TEVATeva Pharmaceutical Industries Ltd
05/07/202214h56Dow Jones NewsAgilent: FDA Approves Teva's Content Uniformity Method Using TRS100 SystemNYSE:TEVATeva Pharmaceutical Industries Ltd
01/07/202214h34Business WireTeva Announces Appointment of New Global R&D and Chief Medical OfficerNYSE:TEVATeva Pharmaceutical Industries Ltd
29/06/202222h09Business WireTeva to Host Conference Call to Discuss Second Quarter 2022 Financial Results at 8 a.m. ET on July 27, 2022NYSE:TEVATeva Pharmaceutical Industries Ltd
26/06/202202h45Business WireTeva veröffentlicht vielversprechende Zwischenergebnisse der PEARL-Studie zur Wirksamkeit von AJOVY® (Fremanezumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

Delayed Upgrade Clock